Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06080698Recruiting
Randomised, open-label trial in gram-negative bacteremia (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Desirability of Outcome Ranking at 30 days. Started Feb 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06080698.